Effect of mud compress therapy on cartilage destruction detected by CTX-II in patients with knee osteoarthritis

Journal of Back and Musculoskeletal Rehabilitation

Volumn 29, Issue 3, 2016, Pages 429-438

  Gungen, Gonca Odemis ^a   Ardic, Fusun ^b   Findikoglu, Gulin ^b   Rota, Simin ^b  

^a Denizli Government Hospital   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

balneotherapy; Biomarker; bone; CTX II; spa; subchondral

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 2; BIOLOGICAL MARKER; C-TERMINAL CROSS-LINKING TELOPEPTIDE OF TYPE II COLLAGEN, HUMAN; PEPTIDE FRAGMENT;

ADULT; AGED; ARTICLE; BODY MASS; CARTILAGE DEGENERATION; COMPARATIVE EFFECTIVENESS; COMPRESSION THERAPY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOT PACK THERAPY; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MUD COMPRESS THERAPY; PAIN ASSESSMENT; PAIN INTENSITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; VISUAL ANALOG SCALE; ARTICULAR CARTILAGE; COMPARATIVE STUDY; KNEE; MIDDLE AGED; MUD THERAPY; OSTEOARTHRITIS, KNEE; PATHOPHYSIOLOGY; URINE;

AGED; BIOMARKERS; CARTILAGE, ARTICULAR; COLLAGEN TYPE II; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; MUD THERAPY; OSTEOARTHRITIS, KNEE; PEPTIDE FRAGMENTS; VISUAL ANALOG SCALE;

EID: 84983413395     PISSN: 10538127     EISSN: 18786324     Source Type: Journal    
DOI: 10.3233/BMR-150629     Document Type: Article

References (81)

1. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: New insights. Part 1: the disease, and its risk factors. Ann Intern Med. 2000; 133(8): 635-46
2. National Center for Chronic Disease Prevention, and Health Promotion (2014) available at: http://www.cdc.gov/arthritis/basics/osteoarthritis.htm (last visited 26th March 2014
3. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patientswith knee osteoarthritis: Relations with disease activity, and joint damage. Ann Rheum Dis. 2001; 60(6): 619-26
4. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone. 2001; 29(3): 209-15
5. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest. 1994; 93(4): 1722-32
6. Downs JT, Lane CL, Nestor NB, McLellan TJ, Kelly MA, Karam GA, et al. Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA. J Immunol Methods. 2001; 247(1-2): 25-34
7. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, et al. Uncoupling of type II collagen synthesis, and degradation predicts progression of joint damage in patients withknee osteoarthritis. Arthritis Rheum. 2002; 46(10): 2613-24
8. Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD. Association of baseline levels of urinary glucosyl-galactosylpyridinoline, and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum 2002; 46: 21-30
9. Conrozier T, Jousseaume CA, Mathieu P, Tron AM, Caton J, Bejui J, et al. Quantitative measurement of joint space narrowing progression in hip osteoarthritis: A longitudinal retrospective study of patients treated by total hip arthroplasty. Rheumatol. 1998; 37(9): 961-8
10. Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis. 2003; 62(10): 939-43
11. Garnero P, Mazières B, Guéguen A, Abbal M, Berdah L, Lequesne M, et al.J Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity andradiological joint damage in patients with hip osteoarthritis: The ECHODIAH cohort. Rheumatol. 2005; 32(4): 697-703
12. Meulenbelt I, Kloppenburg M, Kroon HM, Houwing-Duistermaat JJ, Garnero P, Hellio Le Graverand MP, et al. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: The GARP study. Ann Rheum Dis. 2006; 65(3): 360-5
13. Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau S, Christiansen C, et al. A new marker for osteoarthritis: Cross-sectional, and longitudinal approach. Arthritis Rheum. 2004; 50(8): 2471-8
14. Sowers MF, Karvonen-Gutierrez CA, Yosef M, Jannausch M, Jiang Y, Garnero P, et al. Longitudinal changes of serum COMP, and urinary CTX-II predict X ray defined knee osteoarthritis severity andstiffness in women. Osteoarthritis Car tilage. 2009; 17(12): 1609-14. doi: 10.1016/j.joca.2009.06. 001
15. Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis. 2006; 65(8): 1050-4
16. Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months byMRI. Osteoarthritis Cartilage. 2009; 17(3): 384-9. doi: 10.1016/j. joca.2008.07.009
17. Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, et al. Bone marrow edema, and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003; 139(5Pt 1): 330-6
18. Hunter DJ, Zhang Y, Niu J, Goggins J, Amin S, LaValley MP, et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging studyof knee osteoarthritis. Arthritis Rheum. 2006; 54(5): 1529-35
19. Bettica P, Cline G, Hart DJ, Meyer J, Spector TD. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum. 2002; 46(12): 3178-84
20. Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, Kristensen PW, Kjaersgaard-Andersen P, Sandell L, et al. Biochemical markers of type II collagen breakdown, and synthesis are positioned at specific sites in humanosteoarthritic knee cartilage. Osteoarthritis Cartilage. 2008; 16(5): 615-23
21. Van Spil WE, Jansen NW, Bijlsma JW, Reijman M, DeGroot J, Welsing PM, et al. Clusters within a wide spectrum of biochemical markers for osteoarthritis: Data from CHECK, a large cohort ofindividuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage. 2012; 20(7): 745-54. doi: 10.1016/j.joca.2012.04.004
22. Societe? Internacionale d?Hydrologie Me? dicale. Decisions prises au cours de la Session 1949. In: Proceedings of the IV e Confe? rence Scientifique Internationale de Dax; 1949 Oct 13-16; Dax, France. Imp. Larrat, p. 156-7
23. Odabasi E, Karagulle MZ, Karagulle M, et al. Comparison of two traditional spa therapy regimens in patients with knee osteoarthritis. Phys Med Rehab Kur Med. 2002; 12: 337-341
24. Wigler I, Elkayam O, Paran D, Yaron M. Spa therapy for gonarthrosis: a prospective study. Rheumatol Int. 1995; 15(2): 65-8
25. Flusser D, Abu-Shakra M, Friger M, Codish S, Sukenik S. Therapy with mud compresses for knee osteoarthritis: Comparison of natural mud preparations with mineral-depleted mud. J Clin Rheumatol. 2002; 8(4): 197-203
26. Elkayam O, Wigler I, Tishler M, Rosenblum I, Caspi D, Segal R, et al. Effect of spa therapy in Tiberias on patients with rheumatoid arthritis, and osteoarthritis. J Rheumatol. 1991; 18(12): 1799-803
27. Sukenik S, Buskila D, Neumann L, Kleiner-Baumgarten A. Mud pack therapy in rheumatoid arthritis. Clin Rheumatol. 1992; 11(2): 243-7
28. Codish S, Abu-Shakra M, Flusser D, Friger M, Sukenik S. Mud compress therapy for the hands of patients with rheumatoid arthritis. Rheumatol Int. 2005; 25(1): 49-54
29. Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D, et al. Immediate, and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int. 2000; 19(3): 77-82
30. Karagülle MZ, Karagülle M. Balneotherapy, and spa therapy of rheumatic diseases in Turkey: A systematic review. Forsch Komplementarmed Klass Naturheilkd. 2004; 11(1): 33-41
31. Fioravanti A, Perpignano G, Tirri G, Cardinale G, Gianniti C, Lanza CE, et al. Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial. Rheumatol Int. 2007; 27(12): 1157-61
32. Ardiç F, Ozgen M, Aybek H, Rota S, Cubukçu D, Gökgöz A Effects of balneotherapy on serum IL-1, PGE2, and LTB4 levels in fibromyalgia patients. Rheumatol Int. 2007; 27(5): 441-6
33. Basili S, Martini F, Ferroni P, Grassi M, Sili Scavalli A, Streva P, et al. Effects of mud pack treatment on plasma cytokine, and soluble adhesion molecule levels in healthy volunteer. Clin Chim Acta. 2001; 314(1-2): 209-14
34. Güngen G, Ardic F, Findikoǧlu G, Rota S. The effect of mud pack therapy on serum YKL-40, and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int. 2012; 32(5): 1235-44. doi: 10.1007/s00296-010-1727-4
35. Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoǧlu M. Acceptability, reliability, validity, and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthritis Cartilage. 2005; 13(1): 28-3
36. Garnero P, Landewé R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, et al. Association of baseline levels of markers of bone, and cartilage degradation with long-term progression of jointdamage in patients with early rheumatoid arthritis: The COBRA study. Arthritis Rheum. 2002; 46(11): 2847-56
37. Garnero P, Charni N, Juillet F, Conrozier T, Vignon E. Increased urinary type II collagen helical, and C telopeptide levels are independently associated with a rapidlydestructive hip osteoarthritis. Ann Rheum Dis. 2006; 65(12): 1639-44
38. Gineyts E, Mo JA, Ko A, Henriksen DB, Curtis SP, Gertz BJ, et al. Ann. Effects of ibuprofen on molecular markers of cartilage, and synovium turnover in patients with knee osteoarthritis. Rheum Dis. 2004; 63(7): 857-61
39. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration, and revention ofosteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 2004; 50(4): 1193-206
40. Alexandersen P, Karsdal MA, Qvist P, Reginster JY, Christiansen C. Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone. 2007; 40(1): 218-22
41. Iwamoto J, Takeda T, Sato Y, Matsumoto H. Effects of risedronate on osteoarthritis of the knee. Yonsei Med J. 2010; 51(2): 164-70. doi: 10.3349/ymj.2010.51.2.164
42. Odabasi E, Turan M, Erdem H, Tekbas F. Does mud pack treatment have any chemical effect? A randomized controlled clinical study. J Altern Complement Med. 2008; 14(5): 559-65. doi: 10.1089/acm.2008.0003
43. Matz H, Orion E, Wolf R. Balneotherapy in dermatology. Dermatol Ther. 2003; 16(2): 132-40
44. Tolomio C, Ceschi-Berrini C, Moschin E, Galzigna L. Colonization by diatoms, and antirheumatic activity of thermal mud. Cell Biochem Funct. 1999; 17(1): 29-33
45. Beer AM, Junginger HE, Lukanov J, Sagorchev P. Evaluation of the permeation of peat substances through human skin in vitro. Int J Pharm. 2003; 253(1-2): 169-75
46. Sagorchev, P. Beer, A.-M. Lukanov, J. Influence of aqueous extracts with a definite molecular weight on the spontaneous contractile activity of guinea pig?s stomach smooth muscles. Fol. Med. 1999; 42: 37-42
47. Beer AM, Lukanov J, Sagorchev P. The influence of fulvic, and ulmic acids from peat, on the spontaneous contractile activity of smooth muscles. Phytomedicine. 2000; 7(5): 407-15
48. Beer AM, Sagorchev P, Lukanov J. Isolation of biologically active fractions from the water soluble components of fulvic, and ulmic acids from peat. Phytomedicine. 2002; 9(7): 659-66
49. Cechettin M, Bellometti S, Lalli A, Galzigna L. Serum interleukin-1 changes in arthrosis patients after mud-pack treatment. Phys Rehab Kur Med. 1995; 5: 92-93
50. Bellometti S, Giannini S, Sartori L, Crepaldi G. Cytokine levels in osteoarthrosis patients undergoing mud bath therapy. Int J Clin Pharmacol Res. 1997; 17(4): 149-53
51. Bellometti S, Galzigna L. Serum levels of a prostaglandin, and a leukotriene after thermal mud pack therapy. J Investig Med. 1998; 46(4): 140-5
52. Bellometti S, Richelmi P, Tassoni, Berte F. Production of matrix metalloproteinases, and their inhibitors in osteoarthritic patients undergoing mud bath therapy. Int J Clin Pharmacol Res. 2005; 25(2): 77-94
53. Bellometti S, Cecchettin M, Galzigna L.Mud pack therapy in osteoarthrosis Changes in serum levels of chondrocyte markers. Clinica Chimica Acta. 1997; 268: 101-106
54. Bellometti S, Poletto M, Gregotti C, Richelmi P, Bertè F. Mud bath therapy influences nitric oxide, myeloperoxidase, and glutathione peroxidase serum levels in arthriticpatients. Int J Clin Pharmacol Res. 2000; 20(3-4): 69-80
55. Jokić A, Sremcević N, Karagülle Z, PekmezovíT, Davidoví V. Oxidative stress, hemoglobin content, superoxide dismutase, and catalase activity influenced by sulphur bathsand mud packs in patients with osteoarthritis. Vojnosanit Pregl. 2010; 67(7): 573-8
56. Bellometti S, Cecchettin M, Lalli A, Galzigna L. Mud pack treatment increases serum antioxidant defenses in osteoarthrosic patients. Biomed Pharmacother. 1996; 50(1): 37
57. Shani J, Barak S, Levi D, Ram M, Schachner ER, Schlesinger T, et al. Skin penetration of minerals in psoriatics, and guineapigs bathing in hypertonic salt solutions. Pharmacol Res Commun. 1985; 17(6): 501-12
58. Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, et al. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta, and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage. 2002; 10(6): 491-500
59. Konttinen YT, Mandelin J, Li TF, Salo J, Lassus J, Liljeström M, et al. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage inosteoarthritis. Arthritis Rheum. 2002; 46(4): 953-60
60. Nakase T, Kaneko M, Tomita T, Myoui A, Ariga K, Sugamoto K, et al. Immunohistochemical detection of cathepsin D, K, and L in the process of endochondral ossification in thehuman. Histochem Cell Biol. 2000; 114(1): 21-7
61. Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal, and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008; 22(2): 351-84. doi: 10.1016/j.berh. 2008.02.001
62. Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilagein situ: In vitro mimicking effect by transforming growth factor beta. Arthritis Rheum. 1997; 40(9): 1653-61
63. Chevalier X, Conrozier T. Biological markers for osteoarthritis: An update. Joint Bone Spine. 2005; 72(2): 106-9
64. Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, et al. The human lumbar intervertebral disc: evidence for changes in the biosynthesis anddenaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 1996; 98(4): 996-1003
65. Mouritzen U, Christgau S, Lehmann HJ, Tankó LB, Christiansen C. Cartilage turnover assessed with a newly developed assay measuring collagen type IIdegradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis. 2003; 62(4): 332-6
66. Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB. Diurnal variation of serum, and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum. 2006; 54(8): 2496-504
67. Rousseau JC, Delmas PD. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol. 2007; 3(6): 346-56
68. Sprot H. Associations of CTX-II with biochemical markers of bone turnover raise questions about itstissue origin: Data from CHECK, a cohort study of early osteoarthritis. Ann Rheum Dis. 2013; 72: e20. doi: 10.1136/annrheumdis-2013-203805
69. Christgau S, . Cloos PAS. Cartilage degradation products as markers for evaluation of patients with rheumatic disease. Clin Appl Immunol Rev. 2004; 4: 277-294
70. Cozzi F, Carrara M, Sfriso P, Todesco S, Cima L. Antiinflammatory effect of mud-bath applications on adjuvant arthritis in rats. Clin Exp Rheumatol. 2004; 22(6): 763-6
71. Cozzi F, Lazzarin P, Todesco S, Cima L. Hypothalamicpituitary-adrenal axis dysregulation in healthy subjects undergoing mud-bathapplications. Arthritis Rheum. 1995; 38(5): 724-6
72. Sukenik S, Abu-Shakra M, Flusser D. Balneotherapy in autoimmune disease. Isr J Med Sci. 1997; 33(4): 258-61
73. Jezová D, Vigas M, Tatár P, Jurcovicová J, Palát M. Rise in plasma beta-endorphin, and ACTH in response to hyperthermia in sauna. Horm Metab Res. 1985; 17(12): 693-4
74. Galzigna L, Ceschi-Berrini C, Moschin E, Tolomio C. Thermal mud-pack as an anti-inflammatory treatment. Biomed Pharmacother. 1998; 52(9): 408-9
75. Ghersetich I, Freedman D, Lotti T. Balneology today. J Eur Acad Dermatol Venereol. 2000; 14(5): 346-8
76. Liu H, Zeng C, Gao SG, Yang T, Luo W, Li YS, et al. The effect of mud therapy on pain relief in patients with knee osteoarthritis: A meta-analysis of randomized controlled trials. J Int Med Res. 2013; 41(5): 1418-25. doi: 10.1177/03000 60513488509
77. Françon A1, Forestier R. Spa therapy in rheumatology. Indications based on the clinical guidelines of the French National Authority for health, and the European League Against Rheumatism, and the results of 19 randomized clinical trials. Bull Acad Natl Med. 2009; 193(6): 1345-56; discussion 1356-8
78. Odabaşi E, Turan M, Erdem H, Pay S, Güleç M, Karagülle MZ. The Effect of Mud Pack Treatment in Knee Osteoarthritis. Turk J Rheumato.l 2009; 24: 72-6
79. Evcik D, Kavuncu V, Yeter A, Yigit I. The efficacy of balneotherapy, and mud-pack therapy in patients with knee osteoarthritis. Joint Bone Spine. 2007; 74(1): 60-5
80. Tefner IK, Gaál R, Koroknai A, Ráthonyi A, Gáti T, Monduk P, et al. The effect of Neydharting mud-pack therapy on knee osteoarthritis: A randomized, controlled, double-blind followup pilot study. Rheumatol Int. 2013; 33(10): 2569-76. doi: 10.1007/s00296-013-2776-2
81. Espejo-Antúnez L, Cardero-Durán MA, Garrido-Ardila EM, Torres-Piles S, Caro-Puértolas B. Clinical effectiveness of mud pack therapy in knee osteoarthritis. Rheumatology (Oxford). 2013; 52(4): 659-68. doi: 10.1093/rheumatology/kes322